# FDA Inspection 1111700 - Asclemed USA Inc. dba Enovachem Pharmaceuticals - November 05, 2019

Source: https://www.keypedia.com/records/fda_inspections/asclemed-usa-inc-dba-enovachem-pharmaceuticals/0a7bbf02-c25b-475b-9aec-7f3d6d12e423
Source feed: FDA_Inspections

> FDA Inspection 1111700 for Asclemed USA Inc. dba Enovachem Pharmaceuticals on November 05, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1111700
- Company Name: Asclemed USA Inc. dba Enovachem Pharmaceuticals
- Inspection Date: 2019-11-05
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1263548 - 2025-03-05](https://www.keypedia.com/records/fda_inspections/asclemed-usa-inc-dba-enovachem-pharmaceuticals/e05d8f6f-7810-4e4e-bd4e-9a77716dd0a4)
- [FDA Inspection 1263548 - 2025-03-05](https://www.keypedia.com/records/fda_inspections/asclemed-usa-inc-dba-enovachem-pharmaceuticals/15167392-8298-4b3b-8e3a-158659ffafb5)
- [FDA Inspection 1067059 - 2018-09-27](https://www.keypedia.com/records/fda_inspections/asclemed-usa-inc-dba-enovachem-pharmaceuticals/6f1a6e9b-11cc-426d-aea3-aaa665e9f2a9)
- [FDA Inspection 937934 - 2015-07-15](https://www.keypedia.com/records/fda_inspections/asclemed-usa-inc-dba-enovachem-pharmaceuticals/af56a314-87c9-4068-bb75-413d4f32fc75)
- [FDA Inspection 937934 - 2015-07-15](https://www.keypedia.com/records/fda_inspections/asclemed-usa-inc-dba-enovachem-pharmaceuticals/fb845197-a8df-4d6c-8786-9fe37054e46c)

Company: https://www.keypedia.com/companies/asclemed-usa-inc-dba-enovachem-pharmaceuticals/4accbf56-7f89-4c0a-8196-1290061fb20e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c